#United States #Athens #Dalan Animal Health #Innate Immunity #Shrimp Vaccine

Dalan Animal Health Revolutionizes Disease Prevention with Innate Immunity

Dalan Animal Health, a trailblazing name in bioscience innovation, has recently made significant strides in the realm of food production and disease prevention. Their latest advancements center on a game-changing platform harnessing the power of innate immunity, which has traditionally been viewed as a non-specific defense mechanism. This innovative approach allows the immune system to be systematically trained to provide comprehensive, long-lasting protection against various harmful pathogens. This breakthrough presents promising implications for animal health, food security, and even human health applications in the future.

Innovating Animal Resistance Through Innate Immunity

By targeting innate immunity prenatally, Dalan’s platform successfully enables disease resistance across multiple species. This strategic shift in focus was initially validated with the groundbreaking honeybee vaccine, which has, impressively, already safeguarded over 20,000 honeybee colonies. Dalan is now extending this revolutionary approach to aquatic life with the introduction of the world's first shrimp vaccine, particularly essential for the $45 billion global shrimp industry, which faces numerous threats from diseases.

Dr. Annette Kleiser, CEO of Dalan Animal Health, emphasized the importance of this innovation, stating, "For decades, disease prevention has heavily favored the adaptive immune system. Our research has demonstrated that innate immunity can be trained to provide a groundbreaking solution for protecting animals, ecosystems, and the global food supply."

The novel shrimp vaccine promises to offer an eco-friendly and sustainable alternative to combat significant diseases such as White Spot Syndrome Virus (WSSV) and Early Mortality Syndrome (EMS), both of which pose serious risks to the shrimp farming industry. By employing this innovative method, Dalan is tackling issues that have historically led to substantial economic losses in aquaculture.

Significant Milestones in Shrimp Health

This new vaccine platform has shown remarkable outcomes, with Dalan reporting a 62% absolute survival rate in shrimp exposed to WSSV and a 61% survival rate against EMS. Such impressive results underscore Dalan's pioneering commitment to enhancing biosecurity and reducing dependency on harmful antibiotics and chemical treatments, which have long plagued the aquaculture sector.

Fernando Riaza Carcamo, the Head of Business Development, elucidates the impact of their innovation: "Our progress in the shrimp aquaculture market signifies a vital milestone. By providing a non-chemical solution to combat diseases such as WSSV and EMS, we are not just safeguarding the shrimp population – we are advancing entire ecosystems and food production systems."

Emphasizing Sustainability and Food Security

Dalan Animal Health's efforts extend beyond immediate animal well-being; they are deeply invested in enhancing food security and sustainability. This new method reduces disease-induced economic losses and supports broader initiatives aimed at diminishing antibiotic use, a crucial step in combating antimicrobial resistance.

Dr. Kleiser remarked, "Our mission transcends individual animal health. We are broadening the conventional approach to disease prevention, with potential applications across both invertebrate and vertebrate species. What we offer is more than just a vaccine – it’s a pioneering tool for fostering economic and ecological sustainability."

Looking Ahead: Expanding Applications

Dalan Animal Health remains steadfast in its commitment to pushing the frontiers of immunological research. They continue to explore the extensive applications of their platform in developing groundbreaking solutions for various animal health challenges. With the impending market launch of the shrimp vaccine, Dalan is not just solidifying its status as a leader in sustainable bioscience innovation but is also setting the stage for future advancements.

Dalan Animal Health (www.dalan.com) is dedicated to providing transformative animal health solutions aimed at fostering a sustainable future. Their commitment to expanding vaccine development to other invertebrate species highlights their focus on delivering a secure food supply. Dalan’s remarkable achievements in biotech innovation have garnered numerous accolades, including recognition from notable platforms such as TIME and FORBES. The company operates out of Athens, Georgia, at the University of Georgia's Innovation Hub.